These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10553785)

  • 1. Postexposure prophylaxis for occupational exposure to HIV.
    Bangsberg D; Goldschmidt RH
    JAMA; 1999 Nov; 282(17):1623-4. PubMed ID: 10553785
    [No Abstract]   [Full Text] [Related]  

  • 2. Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus.
    Henderson DK
    JAMA; 1999 Mar; 281(10):931-6. PubMed ID: 10078491
    [No Abstract]   [Full Text] [Related]  

  • 3. [What is the risk of human immunodeficiency virus infection in health personnel? What are the criteria for postexposure prophylaxis?].
    Fariñas MC; Fariñas-Alvarez C
    Enferm Infecc Microbiol Clin; 1999 Dec; 17(10):541-4. PubMed ID: 10650661
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemoprophylaxis after definite occupational exposure to human immunodeficiency virus (HIV).
    Can Fam Physician; 1998 Nov; 44():2388, 2401-3. PubMed ID: 9839054
    [No Abstract]   [Full Text] [Related]  

  • 5. Update on HIV chemoprophylaxis following exposure.
    Flaxman NA; Reed HS
    J Tenn Dent Assoc; 1997 Oct; 77(4):42-4. PubMed ID: 9520762
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical practice. Occupational exposure to HIV in health care settings.
    Gerberding JL
    N Engl J Med; 2003 Feb; 348(9):826-33. PubMed ID: 12606738
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV postexposure prophylaxis in the 21st century.
    Henderson DK
    Emerg Infect Dis; 2001; 7(2):254-8. PubMed ID: 11294718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol for initial evaluation of occupational exposure to HIV and initiation of antiretroviral prophylaxis.
    Shinohara YT; Edwards K; Thompson-Bowers J
    Am J Health Syst Pharm; 1998 Sep; 55(18):1921-4. PubMed ID: 9784773
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV and STD prevention update. New CDC guidelines for HIV postexposure prophylaxis.
    Makulowich GS;
    AIDS Patient Care STDS; 1998 Aug; 12(8):649-53. PubMed ID: 15468437
    [No Abstract]   [Full Text] [Related]  

  • 10. Recommendations for reducing the risk of occupational HIV transmission.
    Paul SM
    N J Med; 2003 Sep; 100(9 Suppl):15-20; quiz 65-6. PubMed ID: 14556598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHS guidelines for management of occupational exposure to HBV, HCV and HIV: HIV postexposure prophylaxis regimens.
    Preboth M;
    Am Fam Physician; 2002 Jan; 65(2):322, 324-5. PubMed ID: 11820492
    [No Abstract]   [Full Text] [Related]  

  • 12. Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 May; 47(RR-7):1-33. PubMed ID: 9603630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raltegravir for postexposure prophylaxis following occupational exposure to HIV.
    Siegel MO; Kan VL; Benator DA
    AIDS; 2008 Nov; 22(18):2552-3. PubMed ID: 19005284
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV postexposure prophylaxis: Who should get it?
    Campos-Outcalt D
    J Fam Pract; 2006 Jul; 55(7):600-4. PubMed ID: 16822447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prophylaxis after occupational exposure to HIV].
    Torten D; Bentwich Z
    Harefuah; 2000 Apr; 138(8):671-7. PubMed ID: 10883211
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers).
    Beekmann SE; Henderson DK
    Infect Dis Clin North Am; 2014 Dec; 28(4):601-13. PubMed ID: 25287589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIV.
    Burty C; Prazuck T; Truchetet F; Christian B; Penalba C; Salmon-Ceron D; Yazdanpanah Y; May T; Rabaud C
    AIDS Patient Care STDS; 2010 Jan; 24(1):1-3. PubMed ID: 20095911
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV postexposure prophylaxis: new recommendations.
    Patrick DM
    CMAJ; 1997 Jan; 156(2):233-4. PubMed ID: 9012728
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolerability of HIV postexposure prophylaxis among healthcare workers.
    Kiertiburanakul S; Wannaying B; Tonsuttakul S; Kehachindawat P; Apivanich S; Somsakul S; Malathum K
    J Hosp Infect; 2006 Jan; 62(1):112-4. PubMed ID: 16099546
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV postexposure prophylaxis availability in U.S. rural hospitals.
    Cocohoba J; Ramay B; Patterson S
    Am J Health Syst Pharm; 2008 Oct; 65(19):1796-7. PubMed ID: 18796416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.